MedPath
NMPA Approval

Lemborexant Tablets

国药准字HJ20250058

EISAI CO

May 20, 2025

Drug Information

莱博雷生片

达卫可

片剂

5mg

化学药品

May 20, 2025

May 19, 2030

Company Information

Applicant Company

EISAI CO

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan

Manufacturing Company

EUROPEAN KNOWLEDGE CENTRE, MOSQUITO WAY, HATFIELD, AL10 9SN, UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

莱博雷生片 - NMPA 批准文号 | MedPath